Please login to your online account to display your discounted pricing

anti-VGLL2, Polyclonal, Novus Biologicals™

Manufacturer: novus biologicals canada  NBP224649SS

 View more versions of this product


For Research Use Only

Catalog No. NBP224649SS

  • / Each

Description & Specifications


Antigen VGLL2
Applications Western Blot
Concentration 0.5mg/mL
Conjugate Unlabeled
Cross Reactivity Bovine
Cross Reactivity Equine
Cross Reactivity Feline
Cross Reactivity Human
Cross Reactivity Porcine
Cross Reactivity Primate
Format Purified
Formulation 100μg in 200μL PBS containing 0.05% BSA
Gene Accession No. Q8N8G2
Host Species Rabbit
Immunogen A portion of amino acids 50-100 of human VGLL2/VITO1 was used as the immunogen.
Isotype IgG
Quantity 0.025mg
Regulatory Status RUO
Primary or Secondary Primary
Monoclonal or Polyclonal Polyclonal
Gene ID (Entrez) 245806
Test Specificity The amino acid sequence used as immunogen is 100% homologous in human, chimpanzee, horse and rat, 95% homologous in cow, 90% homologous in monkey and 85% homologous in mouse and dog.
Target Species Bovine
Target Species Equine
Target Species Feline
Target Species Human
Target Species Porcine
Target Species Primate